% Expired Patents = 50.0

EPO Patents = 7

Forward Citations = 11

Loading Chart...

7 inventors (with patents filed for the assignee):

Birgitte Andersen (4 out of 9 patents)

Karoline Sidelmann Brinch (4 out of 7 patents)

Soeren Kjaerulff (2 out of 7 patents)

4. Tanja Maria Rosenkilde Kjær (2 out of 2 patents)

5. Tanja Maria Rosenkilde Kjaer (2 out of 5 patents)

6. Thomas Kruse (2 out of 5 patents)

7. Per Holse Mygind (2 out of 15 patents)

8. Peter Nordkild (3 patents)

9. Søren Kjærulff (2 patents)

10. Jan Wehkamp (1 patent)

11. Tanja Maria Rosenkilde KJÆR (0 patent)

4 patents: Sort by Forward Citations

1. 9833495 - Oral treatment of inflammatory bowel disease (2017-12-05),

2. 9279010 - Treatment of inflammatory bowel diseases with mammal beta defensins (2016-03-08),

3. 9217021 - Oral treatment of inflammatory bowel disease (2015-12-22),

4. 8802621 - Treatment of inflammatory bowel diseases with mammal beta defensins (2014-08-12),

Defensin Therapeutics Aps is a biotechnology company focused on developing novel therapies based on defensin peptides. These peptides have shown promising potential in combating a wide range of infectious diseases and inflammatory conditions. With a strong focus on research and development, Defensin Therapeutics is committed to advancing these innovative therapies to address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

4 Patents

#3 in Gentofte

#552 in Denmark

Gentofte, Denmark

Defensin Therapeutics Aps